These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 3691123)

  • 1. The effect of fenquizone on the urinary inhibitors of calcium oxalate urolithiasis.
    Cupisti A; Ciardella F; Morelli E; Dani L; Lupetti S; Luchi S; Meola M; Barsotti G
    Contrib Nephrol; 1987; 58():184-6. PubMed ID: 3691123
    [No Abstract]   [Full Text] [Related]  

  • 2. [Resorption of oxalic acid in calcium oxalate nephrolithiasis].
    Müller G; Schütte W; Berg W; Möller T
    Z Urol Nephrol; 1987 Jul; 80(7):391-4. PubMed ID: 3660960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduction of urinary oxalate by combined calcium and citrate administration without increase in urinary calcium oxalate stone formers.
    Ito H; Suzuki F; Yamaguchi K; Nishikawa Y; Kotake T
    Clin Nephrol; 1992 Jan; 37(1):14-8. PubMed ID: 1541059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of cocoa on excretion of oxalate, citrate, magnesium and calcium in the urine of children].
    Lagemann M; Anders D; Graef V; Bödeker RH
    Monatsschr Kinderheilkd; 1985 Oct; 133(10):754-9. PubMed ID: 4069117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The urinary excretion of oxalic acid and magnesium in oxalate urolithiasis.
    Takasaki E; Shimano E
    Invest Urol; 1967 Nov; 5(3):303-12. PubMed ID: 6073639
    [No Abstract]   [Full Text] [Related]  

  • 6. Promoters and inhibitors of calcium urolithiasis in children.
    Lama G; Carbone MG; Marrone N; Russo P; Spagnuolo G
    Child Nephrol Urol; 1990; 10(2):81-4. PubMed ID: 2253256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary excretion of calcium, magnesium, oxalate and citrate in duodenal ulcer patients. Preliminary results before and up to five years after highly selective vagotomy.
    Schwille PO; Scholz D; Hanisch E; Zeuner E; Schwendtner H; Husemann B; Mühe E; Sigel A
    Klin Wochenschr; 1983 Sep; 61(17):845-50. PubMed ID: 6632726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of citrate on the urinary excretion of calcium and oxalate: relevance to calcium oxalate nephrolithiasis.
    Cowley DM; McWhinney BC; Brown JM; Chalmers AH
    Clin Chem; 1989 Jan; 35(1):23-8. PubMed ID: 2910576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Risk indicators of urinary calculus formation: value of oxalate and citrate excretion in comparison with the oxalate tolerance value].
    Hannak D; Burczyk U; Bartelt U; Kattermann R
    Urologe A; 1989 Jan; 28(1):20-4. PubMed ID: 2922896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of urine, pyrophosphate, citrate, magnesium and glycosaminoglycans on the growth and aggregation of calcium oxalate crystals in vitro.
    Ryall RL; Harnett RM; Marshall VR
    Clin Chim Acta; 1981 May; 112(3):349-56. PubMed ID: 6263523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary factors of kidney stone formation in patients with Crohn's disease.
    Böhles H; Beifuss OJ; Brandl U; Pichl J; Akçetin Z; Demling L
    Klin Wochenschr; 1988 Feb; 66(3):87-91. PubMed ID: 3352194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of nifedipine on urinary calcium and oxalate excretion in renal stone formers.
    Baggio B; Gambaro G; Marchini F; Cicerello E; Borsatti A
    Nephron; 1986; 43(3):234-5. PubMed ID: 3724934
    [No Abstract]   [Full Text] [Related]  

  • 13. Indices of lithogenic activity in patients with primitive calcium oxalate urolithiasis.
    Cupisti A; Ciardella F; Morelli E; Lupetti S; Luchi S; Niosi F; Fosso A; Carlini A; Meola M; Barsotti G
    Contrib Nephrol; 1987; 58():82-4. PubMed ID: 3691153
    [No Abstract]   [Full Text] [Related]  

  • 14. Relation between calcium oxalate hydrate form found in renal calculi and some urinary parameters.
    Conte A; Genestar C; Grases F
    Urol Int; 1990; 45(1):25-7. PubMed ID: 2305491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diurnal variations in calcium phosphate and calcium oxalate activity products in normal and stone-forming urines.
    Hodgkinson A; Marshall RW; Cochran M
    Isr J Med Sci; 1971 Nov; 7(11):1230-4. PubMed ID: 5159604
    [No Abstract]   [Full Text] [Related]  

  • 16. [Experimental investigation on the possibility of influencing the solubility of mineral renal stones].
    Knappwost A; Matouschek E
    Urol Int; 1973; 28(1):9-20. PubMed ID: 4693759
    [No Abstract]   [Full Text] [Related]  

  • 17. Reduction of urine oxalate during long-term thiazide therapy in patients with calcium urolithiasis.
    Cohanim M; Yendt ER
    Invest Urol; 1980 Sep; 18(2):170-3. PubMed ID: 7410033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction of the urinary risk factors of urolithiasis with magnesium and tartrate mixture: a new treatment.
    Hallson PC; Rose GA
    Br J Urol; 1988 May; 61(5):382-4. PubMed ID: 3395794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Juvenile renal stone disease: a study of urinary promoting and inhibiting factors.
    Baggio B; Gambaro G; Favaro S; Borsatti A; Pavanello L; Siviero B; Zacchello G; Rizzoni GF
    J Urol; 1983 Dec; 130(6):1133-5. PubMed ID: 6315967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relations between oxalic acid, calcium, magnesium and creatinine excretion in normal men and male patients with calcium oxalate kidney stones.
    Hodgkinson A
    Clin Sci Mol Med; 1974 Mar; 46(3):357-67. PubMed ID: 4818216
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.